GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.87 $1.65 Friday, 19th Apr 2024 ADAP stock ended at $0.98. This is 8.72% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 17.39% from a day low at $0.92 to a day high of $1.08.
90 days $0.691 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
2020-11-30 $4.99 $5.06 $4.87 $5.01 2 562 429
2020-11-27 $4.65 $4.97 $4.62 $4.91 1 221 491
2020-11-25 $4.35 $4.74 $4.25 $4.61 1 293 049
2020-11-24 $4.57 $4.57 $4.30 $4.37 1 500 304
2020-11-23 $4.99 $4.99 $4.45 $4.55 1 815 960
2020-11-20 $4.89 $5.09 $4.66 $4.97 1 339 719
2020-11-19 $4.77 $4.88 $4.60 $4.72 705 879
2020-11-18 $4.84 $4.92 $4.57 $4.75 1 010 039
2020-11-17 $5.03 $5.09 $4.68 $4.82 880 099
2020-11-16 $5.00 $5.09 $4.86 $5.03 743 255
2020-11-13 $4.80 $5.08 $4.80 $4.99 710 147
2020-11-12 $4.94 $4.97 $4.72 $4.80 840 238
2020-11-11 $4.97 $5.10 $4.86 $4.89 1 280 233
2020-11-10 $5.18 $5.18 $4.82 $4.88 1 195 968
2020-11-09 $5.27 $5.74 $5.02 $5.22 2 815 913
2020-11-06 $5.33 $5.38 $5.15 $5.21 667 021
2020-11-05 $5.45 $5.68 $5.16 $5.31 1 164 304
2020-11-04 $5.23 $5.76 $5.21 $5.30 2 055 192
2020-11-03 $5.22 $5.36 $4.94 $5.23 969 425
2020-11-02 $4.61 $5.18 $4.55 $5.15 1 460 513
2020-10-30 $4.54 $4.64 $4.26 $4.51 1 152 297
2020-10-29 $4.44 $4.63 $4.15 $4.53 6 768 873
2020-10-28 $4.77 $4.77 $4.35 $4.40 1 691 608
2020-10-27 $4.99 $4.99 $4.65 $4.78 857 957
2020-10-26 $4.69 $5.12 $4.61 $4.87 1 585 319
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT